Teva reports third quarter 2021 financial results

Tel aviv, israel--(business wire)--teva pharmaceutical industries ltd. (nyse and tase: teva) today reported results for the quarter ended september 30, 2021. mr. kÅre schultz, teva's president and ceo, said, "i am very happy with our solid performance in the third quarter of 2021, especially our strong cash flow and continued momentum with key brands. our results were driven by robust performance of ajovy® in the u.s., europe and japan as well as u.s. sales of austedo®, our novel therapy for th
TEVA Ratings Summary
TEVA Quant Ranking